These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 36965349)
1. Cannabinoids and the placenta: Receptors, signaling and outcomes. Rokeby ACE; Natale BV; Natale DRC Placenta; 2023 Apr; 135():51-61. PubMed ID: 36965349 [TBL] [Abstract][Full Text] [Related]
2. Suppression of STAT3 Signaling by Δ9-Tetrahydrocannabinol (THC) Induces Trophoblast Dysfunction. Chang X; Bian Y; He Q; Yao J; Zhu J; Wu J; Wang K; Duan T Cell Physiol Biochem; 2017; 42(2):537-550. PubMed ID: 28578322 [TBL] [Abstract][Full Text] [Related]
3. Expression of the endocannabinoid system and response to cannabinoid components by the human fetal testis. Dochez-Arnault J; Desdoits-Lethimonier C; Matias I; Evrard B; Lagarrigue M; Toupin M; Lardenois A; Chalmel F; Mazaud-Guittot S; Dejucq-Rainsford N; Gely-Pernot A BMC Med; 2023 Jul; 21(1):219. PubMed ID: 37430350 [TBL] [Abstract][Full Text] [Related]
4. Effects of a combination of cannabidiol and delta-9-tetrahydrocannabinol on key biological functions of HTR-8/SVneo extravillous trophoblast cells. Alves P; Amaral C; Teixeira N; Correia-da-Silva G Toxicology; 2023 Aug; 495():153614. PubMed ID: 37567336 [TBL] [Abstract][Full Text] [Related]
5. Characterization of cannabinoid plasma concentration, maternal health, and cytokine levels in a rat model of prenatal Cannabis smoke exposure. Black T; Baccetto SL; Barnard IL; Finch E; McElroy DL; Austin-Scott FVL; Greba Q; Michel D; Zagzoog A; Howland JG; Laprairie RB Sci Rep; 2023 Nov; 13(1):21070. PubMed ID: 38030657 [TBL] [Abstract][Full Text] [Related]
6. The Cannabinoid Delta-9-tetrahydrocannabinol Disrupts Estrogen Signaling in Human Placenta. Maia J; Almada M; Midão L; Fonseca BM; Braga J; Gonçalves D; Teixeira N; Correia-da-Silva G Toxicol Sci; 2020 Oct; 177(2):420-430. PubMed ID: 32647869 [TBL] [Abstract][Full Text] [Related]
7. Δ9-tetrahydrocannabinol exposure during rat pregnancy leads to symmetrical fetal growth restriction and labyrinth-specific vascular defects in the placenta. Natale BV; Gustin KN; Lee K; Holloway AC; Laviolette SR; Natale DRC; Hardy DB Sci Rep; 2020 Jan; 10(1):544. PubMed ID: 31953475 [TBL] [Abstract][Full Text] [Related]
8. Metabolic Consequences of Gestational Cannabinoid Exposure. Lee K; Hardy DB Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502436 [TBL] [Abstract][Full Text] [Related]
9. Cannabidiol Exposure During Rat Pregnancy Leads to Labyrinth-Specific Vascular Defects in the Placenta and Reduced Fetal Growth. Allen S; Natale BV; Ejeckam AO; Lee K; Hardy DB; Natale DRC Cannabis Cannabinoid Res; 2024 Jun; 9(3):766-780. PubMed ID: 38364116 [No Abstract] [Full Text] [Related]
10. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Pertwee RG Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291 [TBL] [Abstract][Full Text] [Related]
11. Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations. Moore CF; Weerts EM Psychopharmacology (Berl); 2022 May; 239(5):1397-1408. PubMed ID: 34652500 [TBL] [Abstract][Full Text] [Related]
12. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids. Hindelang P; Scharinger A; Richling E; Walch SG; Lachenmeier DW Front Biosci (Landmark Ed); 2022 Jul; 27(8):228. PubMed ID: 36042166 [TBL] [Abstract][Full Text] [Related]
13. Synthetic cannabinoids JWH-018, JWH-122, UR-144 and the phytocannabinoid THC activate apoptosis in placental cells. Almada M; Alves P; Fonseca BM; Carvalho F; Queirós CR; Gaspar H; Amaral C; Teixeira NA; Correia-da-Silva G Toxicol Lett; 2020 Feb; 319():129-137. PubMed ID: 31730886 [TBL] [Abstract][Full Text] [Related]
14. CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposure. Lambros AM; Sagar KA; Dahlgren MK; Kosereisoglu D; El-Abboud C; Smith RT; Gruber SA Sci Rep; 2023 Apr; 13(1):5869. PubMed ID: 37041309 [TBL] [Abstract][Full Text] [Related]
15. Toxicological properties of Δ9-tetrahydrocannabinol and cannabidiol. Černe K Arh Hig Rada Toksikol; 2020 Mar; 71(1):1-11. PubMed ID: 32597140 [TBL] [Abstract][Full Text] [Related]
16. Prenatal cannabinoid and gene expression for neural adhesion molecule L1 in the fetal rat brain. Gómez M; Hernández M; Johansson B; de Miguel R; Ramos JA; Fernández-Ruiz J Brain Res Dev Brain Res; 2003 Dec; 147(1-2):201-7. PubMed ID: 15068010 [TBL] [Abstract][Full Text] [Related]
17. Examining the role of cannabinoids on osteoporosis: a review. Clouse G; Penman S; Hadjiargyrou M; Komatsu DE; Thanos PK Arch Osteoporos; 2022 Nov; 17(1):146. PubMed ID: 36401719 [TBL] [Abstract][Full Text] [Related]
18. Chronic prenatal delta-9-tetrahydrocannabinol exposure adversely impacts placental function and development in a rhesus macaque model. Roberts VHJ; Schabel MC; Boniface ER; D'Mello RJ; Morgan TK; Terrobias JJD; Graham JA; Borgelt LM; Grant KA; Sullivan EL; Lo JO Sci Rep; 2022 Nov; 12(1):20260. PubMed ID: 36424495 [TBL] [Abstract][Full Text] [Related]
19. Cannabidiol and Δ8-Tetrahydrocannabinol: Cannabinoids of Rising Interest and Concern. White RM Forensic Sci Rev; 2023 Jan; 35(1):27-45. PubMed ID: 36575371 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa. Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]